SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Metlife Inc – ‘10-Q’ for 3/31/16 – ‘EX-18.1’

On:  Thursday, 5/5/16, at 6:15pm ET   ·   As of:  5/6/16   ·   For:  3/31/16   ·   Accession #:  937834-16-99   ·   File #:  1-15787

Previous ‘10-Q’:  ‘10-Q’ on 11/5/15 for 9/30/15   ·   Next:  ‘10-Q’ on 8/5/16 for 6/30/16   ·   Latest:  ‘10-Q’ on 11/2/23 for 9/30/23   ·   4 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/06/16  Metlife Inc                       10-Q        3/31/16  121:33M                                    Metropolitan Life Ins Co

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   2.46M 
 2: EX-10.1     Material Contract                                   HTML    519K 
 3: EX-18.1     Letter re: Change in Accounting Principles          HTML     35K 
 4: EX-31.1     Certification -- §302 - SOA'02                      HTML     40K 
 5: EX-31.2     Certification -- §302 - SOA'02                      HTML     40K 
 6: EX-32.1     Certification -- §906 - SOA'02                      HTML     35K 
 7: EX-32.2     Certification -- §906 - SOA'02                      HTML     35K 
14: R1          Document and Entity Information                     HTML     62K 
15: R2          Consolidated Balance Sheets (Unaudited)             HTML    161K 
16: R3          Consolidated Balance Sheets (Unaudited)             HTML    129K 
                (Parenthetical)                                                  
17: R4          Consolidated Statements of Operations and           HTML    119K 
                Comprehensive Income (Unaudited)                                 
18: R5          Consolidated Statements of Equity (Unaudited)       HTML     78K 
19: R6          Consolidated Statements of Cash Flows (Unaudited)   HTML    138K 
20: R7          Business, Basis of Presentation and Summary of      HTML     60K 
                Significant Accounting Policies                                  
21: R8          Segment Information                                 HTML    448K 
22: R9          Pending Disposition                                 HTML     38K 
23: R10         Insurance                                           HTML    101K 
24: R11         Closed Block                                        HTML    124K 
25: R12         Investments                                         HTML    937K 
26: R13         Derivatives                                         HTML    718K 
27: R14         Fair Value                                          HTML   1.07M 
28: R15         Equity                                              HTML    208K 
29: R16         Other Expenses                                      HTML     58K 
30: R17         Employee Benefit Plans                              HTML     67K 
31: R18         Earnings Per Common Share                           HTML     62K 
32: R19         Contingencies, Commitments and Guarantees           HTML    115K 
33: R20         Subsequent Event                                    HTML     38K 
34: R21         Business, Basis of Presentation and Summary of      HTML    106K 
                Significant Accounting Policies (Policies)                       
35: R22         Segment Information (Tables)                        HTML    414K 
36: R23         Insurance (Tables)                                  HTML     98K 
37: R24         Closed Block (Tables)                               HTML    126K 
38: R25         Investments (Tables)                                HTML    933K 
39: R26         Derivatives (Tables)                                HTML    741K 
40: R27         Fair Value (Tables)                                 HTML   1.10M 
41: R28         Equity (Tables)                                     HTML    201K 
42: R29         Other Expenses (Tables)                             HTML     58K 
43: R30         Employee Benefit Plans (Tables)                     HTML     65K 
44: R31         Earnings Per Common Share (Tables)                  HTML     60K 
45: R32         Business, Basis of Presentation and Summary of      HTML     36K 
                Significant Accounting Policies (Narrative)                      
                (Details)                                                        
46: R33         Segment Information (Earnings) (Details)            HTML    157K 
47: R34         Segment Information (Total Assets) (Details)        HTML     52K 
48: R35         Segment Information (Narrative) (Details)           HTML     35K 
49: R36         Pending Disposition (Pending Disposition -          HTML     38K 
                Narrative) (Details)                                             
50: R37         Insurance (Guarantees Related to Annuity            HTML     54K 
                Contracts) (Details)                                             
51: R38         Insurance (Guarantees Related to Universal and      HTML     48K 
                Variable Life Contracts) (Details)                               
52: R39         Closed Block (Liabilities and Assets) (Details)     HTML    108K 
53: R40         Closed Block (Policyholder Dividend Obligation)     HTML     41K 
                (Details)                                                        
54: R41         Closed Block (Revenues and Expenses) (Details)      HTML     64K 
55: R42         Investments (Fixed Maturity and Equity Securities   HTML    102K 
                Available-For-Sale by Sector) (Details)                          
56: R43         Investments (Maturities of Fixed Maturity           HTML     72K 
                Securities) (Details)                                            
57: R44         Investments (Continuous Gross Unrealized Losses     HTML     93K 
                for Fixed Maturity and Equity Securities                         
                Available-For-Sale) (Details)                                    
58: R45         Investments (Mortgage Loans by Portfolio Segment)   HTML     79K 
                (Details)                                                        
59: R46         Investments (Mortgage Loans and Valuation           HTML     67K 
                Allowance by Portfolio Segment) (Details)                        
60: R47         Investments (Valuation Allowance Rollforward by     HTML     52K 
                Portfolio Segment) (Details)                                     
61: R48         Investments (Credit Quality of Commercial Mortgage  HTML     75K 
                Loans) (Details)                                                 
62: R49         Investments (Credit Quality of Agricultural and     HTML     61K 
                Residential Mortgage Loans) (Details)                            
63: R50         Investments (Past Due and Interest Accrual Status   HTML     46K 
                of Mortgage Loans) (Details)                                     
64: R51         Investments (Net Unrealized Investment Gains        HTML     72K 
                Losses) (Details)                                                
65: R52         Investments (Changes in Fixed Maturity Securities   HTML     44K 
                with Noncredit OTTI Losses) (Details)                            
66: R53         Investments (Changes in Net Unrealized Investment   HTML     65K 
                Gains Losses) (Details)                                          
67: R54         Investments (Securities Lending) (Details)          HTML     49K 
68: R55         Investments (Securities Lending Remaining Tenor)    HTML     74K 
                (Details)                                                        
69: R56         Investments (Invested Assets on Deposit, Held In    HTML     43K 
                Trust and Pledged as Collateral) (Details)                       
70: R57         Investments (Consolidated Variable Interest         HTML     49K 
                Entities) (Details)                                              
71: R58         Investments (Unconsolidated Variable Interest       HTML     60K 
                Entities) (Details)                                              
72: R59         Investments (Net Investment Income) (Details)       HTML     77K 
73: R60         Investments (Components of Net Investment Gains     HTML     93K 
                Losses) (Details)                                                
74: R61         Investments (Sales or Disposals and Impairments of  HTML     53K 
                Fixed Maturity and Equity Securities) (Details)                  
75: R62         Investments (Credit Loss Rollforward) (Details)     HTML     48K 
76: R63         Investments (Fixed Maturity and Equity Securities   HTML     48K 
                Available-For-Sale - Narrative) (Details)                        
77: R64         Investments (Evaluation of Available-For-Sale       HTML     72K 
                Securities for OTTI and Evaluating Temporarily                   
                Impaired AFS Securities - Narrative) (Details)                   
78: R65         Investments (Mortgage Loans - Narrative) (Details)  HTML     51K 
79: R66         Investments (Cash Equivalents - Narrative)          HTML     37K 
                (Details)                                                        
80: R67         Investments (Concentrations of Credit Risk -        HTML     47K 
                Narrative) (Details)                                             
81: R68         Investments (Securities Lending - Narrative)        HTML     45K 
                (Details)                                                        
82: R69         Investments (Securities Lending Remaining Tenor -   HTML     45K 
                Narrative) (Details)                                             
83: R70         Investments (Repurchase Agreement - Narrative)      HTML     61K 
                (Details)                                                        
84: R71         Investments (Variable Interest Entities -           HTML     51K 
                Narrative) (Details)                                             
85: R72         Investments (Net Investment Gains Losses -          HTML     37K 
                Narrative) (Details)                                             
86: R73         Derivatives (Primary Risks) (Details)               HTML    121K 
87: R74         Derivatives (Net Derivative Gains Losses)           HTML     40K 
                (Details)                                                        
88: R75         Derivatives (Earned Income On Derivatives)          HTML     51K 
                (Details)                                                        
89: R76         Derivatives (Gains Losses Recognized in Income Not  HTML     68K 
                Designated or Qualifying) (Details)                              
90: R77         Derivatives (Fair Value Hedges) (Details)           HTML     59K 
91: R78         Derivatives (Cash Flow Hedges) (Details)            HTML     70K 
92: R79         Derivatives (Hedges of Net Investments in Foreign   HTML     42K 
                Operations) (Details)                                            
93: R80         Derivatives (Credit Derivatives) (Details)          HTML     70K 
94: R81         Derivatives (Estimated Fair Value of Derivative     HTML     88K 
                Assets and Liabilities after Master Netting                      
                Agreements and Cash Collateral) (Details)                        
95: R82         Derivatives (Credit Risk on Freestanding            HTML     59K 
                Derivatives) (Details)                                           
96: R83         Derivatives (Embedded Derivatives) (Details)        HTML     60K 
97: R84         Derivatives (Changes in Estimated Fair Value        HTML     41K 
                Related to Embedded Derivatives) (Details)                       
98: R85         Derivatives (Narrative) (Details)                   HTML    133K 
99: R86         Fair Value (Recurring Fair Value Measurements)      HTML    223K 
                (Details)                                                        
100: R87         Fair Value (Quantitative Information) (Details)     HTML    125K  
101: R88         Fair Value (Unobservable Input Reconciliation)      HTML    196K  
                (Details)                                                        
102: R89         Fair Value (Fair Value Option for Certain Assets    HTML     58K  
                and Liabilities) (Details)                                       
103: R90         Fair Value (Nonrecurring Fair Value Measurements)   HTML     50K  
                (Details)                                                        
104: R91         Fair Value (Financial Instruments Carried at Other  HTML     96K  
                Than Fair Value) (Details)                                       
105: R92         Fair Value (Recurring Fair Value Measurements)      HTML     39K  
                (Narrative) (Details)                                            
106: R93         Fair Value (Transfers Between Levels) (Narrative)   HTML     36K  
                (Details)                                                        
107: R94         Fair Value (Nonrecurring Fair Value Measurements)   HTML     41K  
                (Narrative) (Details)                                            
108: R95         Equity (Preferred Stock) (Details)                  HTML     53K  
109: R96         Equity (Components of Accumulated Other             HTML     74K  
                Comprehensive Income (Loss)) (Details)                           
110: R97         Equity (Reclassifications Out of Accumulated Other  HTML     81K  
                Comprehensive Income (Loss)) (Details)                           
111: R98         Equity (Common Stock - Narrative) (Details)         HTML     39K  
112: R99         Equity (Stock-Based Compensation Plans -            HTML     52K  
                Narrative) (Details)                                             
113: R100        Other Expenses (Other Expenses) (Details)           HTML     62K  
114: R101        Employee Benefit Plans (Net Periodic Benefit        HTML     59K  
                Costs) (Details)                                                 
115: R102        Earnings Per Common Share (Earnings Per Common      HTML     64K  
                Share) (Details)                                                 
116: R103        Contingencies, Commitments and Guarantees           HTML     68K  
                (Contingencies - Narrative) (Details)                            
117: R104        Contingencies, Commitments and Guarantees           HTML     51K  
                (Commitments and Guarantees - Narrative) (Details)               
118: R105        Subsequent Event (Details)                          HTML     40K  
120: XML         IDEA XML File -- Filing Summary                      XML    236K  
119: EXCEL       IDEA Workbook of Financial Reports                  XLSX    191K  
 8: EX-101.INS  XBRL Instance -- met-20160331                        XML  12.48M 
10: EX-101.CAL  XBRL Calculations -- met-20160331_cal                XML    310K 
11: EX-101.DEF  XBRL Definitions -- met-20160331_def                 XML   1.49M 
12: EX-101.LAB  XBRL Labels -- met-20160331_lab                      XML   3.16M 
13: EX-101.PRE  XBRL Presentations -- met-20160331_pre               XML   2.04M 
 9: EX-101.SCH  XBRL Schema -- met-20160331                          XSD    305K 
121: ZIP         XBRL Zipped Folder -- 0000937834-16-000099-xbrl      Zip    677K  


‘EX-18.1’   —   Letter re: Change in Accounting Principles


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Exhibit  

Exhibit 18.1
May 5, 2016

MetLife, Inc.
1095 Avenue of the Americas
New York, New York 10036


To the Board of Directors and Stockholders of MetLife, Inc.:
At your request, we have read the description included in your Quarterly Report on Form 10-Q to the Securities and Exchange Commission for the quarter ended March 31, 2016, of the facts relating to the change to eliminate the financial reporting lag for the Company’s subsidiary in Japan to align with the Company’s fiscal year-end. We believe, on the basis of the facts so set forth and other information furnished to us by appropriate officials of MetLife, Inc., that the accounting change described in your Form 10-Q is to an alternative accounting principle that is preferable under the circumstances.
We have not audited any consolidated financial statements of MetLife, Inc. and its subsidiaries as of any date or for any period subsequent to December 31, 2015. Therefore, we are unable to express, and we do not express, an opinion on the facts set forth in the above-mentioned Form 10-Q, on the related information furnished to us by officials of MetLife, Inc., or on the financial position, results of operations, or cash flows of MetLife, Inc. and its subsidiaries as of any date or for any period subsequent to December 31, 2015.

Yours truly,

/s/ Deloitte & Touche LLP
New York, New York



Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed as of:5/6/16SC 13D/A
Filed on:5/5/16SC 13D/A
For Period end:3/31/164,  PRE 14A
12/31/1510-K,  11-K,  ARS
 List all Filings 


4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/16/24  MetLife, Inc.                     10-K       12/31/23  265:78M
 2/23/23  MetLife, Inc.                     10-K       12/31/22  244:62M
 2/18/22  MetLife, Inc.                     10-K       12/31/21  253:63M
 2/19/21  MetLife, Inc.                     10-K       12/31/20  245:65M
Top
Filing Submission 0000937834-16-000099   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 27, 2:22:43.2am ET